ArticleFrontiers in genetics2020

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment.

Ruibin Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.